One proof of concept that explains the involvement of lipid dysregulation in the pathogenesis of PD/DLB is that GBA1 mutations increase the risk of PD/DLB (Tayebi et al., 2003; Goker-Alpan et al., 2004; Sidransky and Lopez, 2012). This evidence concerns the gene GBA1 and Parkinson disease.